Kevin D. Bunker, Chief Operating Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 28,750 shares at $67.24 ($1.4M) on 2022-01-10, disclosed to the SEC on 2022-01-11.
Open-market sale of $1.4M ZNTL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 8,750 | $0 | 0.0% |
| 2 | $67.24 | 3,146 | $212K | 15.5% |
| 3 | $67.24 | 3,146 | $212K | 15.5% |
| 4 | $68.05 | 2,807 | $191K | 14.0% |
| 5 | $68.05 | 2,807 | $191K | 14.0% |
| 6 | $69.03 | 1,835 |
| $127K |
| 9.3% |
| 7 | $69.03 | 1,835 | $127K | 9.3% |
| 8 | $70.02 | 2,212 | $155K | 11.3% |
| 9 | $70.02 | 2,212 | $155K | 11.3% |
| Total | $47.59 avg | 28,750 | $1.4M | 100% |
| Filing → |
| ZNTL | SELL | 2023-02-14 | $285K | — | Filing → |
| ZNTL | SELL | 2022-08-12 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |